HighVista Strategies LLC - Q4 2020 holdings

$157 Million is the total value of HighVista Strategies LLC's 117 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 65.2% .

 Value Shares↓ Weighting
BABA SellALIBABA GROUP HLDG LTDsponsored ads$7,282,000
-30.8%
31,289
-12.6%
4.65%
-39.4%
STRO SellSUTRO BIOPHARMA INC$1,369,000
+110.3%
63,053
-2.5%
0.87%
+84.4%
TSM SellTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$955,000
+17.8%
8,756
-12.4%
0.61%
+3.2%
KURA SellKURA ONCOLOGY INC$807,000
+6.0%
24,708
-0.5%
0.52%
-7.2%
ZYME SellZYMEWORKS INC$690,000
-9.2%
14,608
-10.4%
0.44%
-20.4%
MBT SellMOBILE TELESYSTEMS PJSCsponsored adr$289,000
-45.1%
32,259
-46.4%
0.18%
-51.7%
UBS SellUBS GROUP AG$162,000
+4.5%
12,991
-13.9%
0.10%
-8.8%
IMGN SellIMMUNOGEN INC$143,000
+49.0%
22,100
-17.5%
0.09%
+30.0%
AFMD SellAFFIMED N V$105,000
+28.0%
18,035
-25.5%
0.07%
+11.7%
UTI SellUNIVERSAL TECHNICAL INST INC$96,000
+23.1%
14,793
-3.3%
0.06%
+7.0%
TRUE SellTRUECAR INC$94,000
-36.9%
22,400
-24.6%
0.06%
-45.0%
SURF SellSURFACE ONCOLOGY INC$93,000
-4.1%
10,100
-27.9%
0.06%
-16.9%
VRA SellVERA BRADLEY INC$93,000
-34.0%
11,737
-49.2%
0.06%
-42.7%
ASMB SellASSEMBLY BIOSCIENCES INC$90,000
-79.5%
14,867
-44.3%
0.06%
-82.2%
ARAY SellACCURAY INC$87,000
+27.9%
20,938
-26.0%
0.06%
+12.0%
RIGL SellRIGEL PHARMACEUTICALS INC$79,000
+3.9%
22,541
-29.1%
0.05%
-9.1%
DHX ExitDHI GROUP INC$0-15,100
-100.0%
-0.02%
DVAX ExitDYNAVAX TECHNOLOGIES CORP$0-14,700
-100.0%
-0.05%
AGTC ExitAPPLIED GENETIC TECHNOLOGIES$0-15,200
-100.0%
-0.05%
RBBN ExitRIBBON COMMUNICATIONS INC$0-19,700
-100.0%
-0.06%
LUNA ExitLUNA INNOVATIONS$0-12,900
-100.0%
-0.06%
BDSI ExitBIODELIVERY SCIENCES INTL IN$0-22,600
-100.0%
-0.06%
CTMX ExitCYTOMX THERAPEUTICS INC$0-13,000
-100.0%
-0.06%
FPRX ExitFIVE PRIME THERAPEUTICS INC$0-20,500
-100.0%
-0.07%
SONA ExitSOUTHERN NATL BANCORP OF VA$0-11,500
-100.0%
-0.07%
RYI ExitRYERSON HLDG CORP$0-18,100
-100.0%
-0.08%
BZH ExitBEAZER HOMES USA INC$0-10,300
-100.0%
-0.10%
QNST ExitQUINSTREET INC$0-12,400
-100.0%
-0.14%
ZGNX ExitZOGENIX INC$0-19,492
-100.0%
-0.25%
PRTA ExitPROTHENA CORP PLC$0-44,414
-100.0%
-0.32%
DRNA ExitDICERNA PHARMACEUTICALS INC$0-24,920
-100.0%
-0.33%
XENE ExitXENON PHARMACEUTICALS INC$0-43,517
-100.0%
-0.35%
CRNX ExitCRINETICS PHARMACEUTICALS IN$0-30,845
-100.0%
-0.35%
BDTX ExitBLACK DIAMOND THERAPEUTICS I$0-16,391
-100.0%
-0.36%
MTEM ExitMOLECULAR TEMPLATES INC$0-47,372
-100.0%
-0.38%
FATE ExitFATE THERAPEUTICS INC$0-13,807
-100.0%
-0.40%
XNCR ExitXENCOR INC$0-14,315
-100.0%
-0.40%
DNLI ExitDENALI THERAPEUTICS INC$0-15,734
-100.0%
-0.41%
INSM ExitINSMED INC$0-17,635
-100.0%
-0.41%
KOD ExitKODIAK SCIENCES INC$0-10,097
-100.0%
-0.44%
MYOK ExitMYOKARDIA INC$0-4,780
-100.0%
-0.48%
IMMU ExitIMMUNOMEDICS INC$0-11,722
-100.0%
-0.73%
WMGI ExitWRIGHT MED GROUP N V$0-97,960
-100.0%
-2.18%
DLPH ExitDELPHI TECHNOLOGIES PL$0-189,132
-100.0%
-2.30%
LVGO ExitLIVONGO HEALTH INC$0-24,925
-100.0%
-2.54%
AMTD ExitTD AMERITRADE HLDG CORP$0-182,630
-100.0%
-5.21%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSDIGM GROUP INC29Q2 20232.9%
VANGUARD INDEX FDS24Q4 201926.4%
APPLE INC24Q4 20192.0%
ISHARES TR22Q3 20187.9%
MICROSOFT CORP21Q3 20232.0%
VISA INC20Q3 20235.8%
INVESCO DB COMMDY INDX TRCK20Q3 202316.6%
VERIZON COMMUNICATIONS INC20Q4 20190.4%
ALIBABA GROUP HLDG LTD19Q3 20237.7%
AMAZON COM INC19Q3 20232.9%

View HighVista Strategies LLC's complete holdings history.

Latest significant ownerships (13-D/G)
HighVista Strategies LLC Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
STG Group, Inc.Sold outFebruary 16, 201600.0%
SAExploration Holdings, Inc.February 12, 201425,0000.2%
Trio Merger Corp.February 14, 2013690,0008.8%

View HighVista Strategies LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View HighVista Strategies LLC's complete filings history.

Compare quarters

Export HighVista Strategies LLC's holdings